Survival bene fi t of cabazitaxel in castration-resistant prostate cancer patients predicted with poor prognosis

被引：0
|
作者：
Hashimoto, Kohei [1 ,3 ]
Tanaka, Toshiaki [1 ,3 ]
Tabata, Hidetoshi [1 ]
Takayanagi, Akio [1 ]
Shindo, Tetsuya [1 ,3 ]
Yamamoto, Takanobu [1 ]
Shibamori, Kosuke [1 ]
Kato, Shuichi [1 ]
Hashimoto, Jiro [1 ]
Inoue, Ryuta [1 ]
Muranaka, Takashi [1 ]
Takahashi, Atsushi [2 ,3 ]
Masumori, Naoya [1 ,3 ]
机构：
[1] Sapporo Med Univ, Sapporo, Hokkaido, Japan
[2] Hakodate Goryokaku Hosp, Hakodate, Hokkaido, Japan
[3] Sapporo Med Univ, Urol Oncol Consortium, Sapporo, Hokkaido, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
IS-29
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [21] Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancer
    Pobel, Cedric
    Auclin, Edouard
    Teyssonneau, Diego
    Laguerre, Brigitte
    Cancel, Mathilde
    Boughalem, Elouen
    Noel, Johanna
    Brachet, Pierre Emmanuel
    Maillet, Denis
    Barthelemy, Philippe
    Helissey, Carole
    Thibault, Constance
    Oudard, Stephane
    CANCER MEDICINE, 2021, 10 (18): : 6304 - 6309
  • [22] Predicting prognosis in castration-resistant prostate cancer
    Nature Reviews Cancer, 2012, 12 (11) : 736 - 736
  • [23] Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer
    Hongo, Hiroshi
    Kosaka, Takeo
    Oya, Mototsugu
    CANCER SCIENCE, 2018, 109 (09) : 2937 - 2945
  • [24] Meaningful survival after cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC): The Spanish experience.
    Gonzalez Maeso, Iria
    Castellano, Daniel E.
    Campos Balea, Begona
    Esteban, Emilio
    Perez Arnillas, Quionia
    Villalobos Leon, M. Laura
    Munarriz, Javier
    Rubio, Gustavo
    Cumplido Buron, Jose David
    Garcia Sanchez, Jose
    Martin, Almudena
    Maria Garcia-Bueno, Jose
    Reyes Garcia, Ana
    Perez-Valderrama, Begona
    Anido Herranz, Urbano
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [25] Efficacy of Carboplatin and Cabazitaxel in heavily pretreated Patients with metastatic castration-resistant Prostate Cancer
    Strewinsky, N.
    Dyshlovoy, S. A.
    Schuettfort, V. M.
    Oh-Hohenhorst, S. J.
    Tilki, D.
    Graefen, M.
    Bokemeyer, C.
    von Amsberg, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 187 - 187
  • [26] Efficacy of Carboplatin and Cabazitaxel in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer
    Strewinsky, Nadja
    Dyshlovoy, Sergey A.
    Schuettfort, Victor M.
    Tilki, Derya
    Oh-Hohenhorst, Su Jung
    Graefen, Markus
    Bokemeyer, Carsten
    von Amsberg, Gunhild
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 263 - 263
  • [27] IMPROVED SURVIVAL PROSPECTS FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
    Kirby, Roger S.
    Fitzpatrick, John M.
    BJU INTERNATIONAL, 2011, 107 (05) : 697 - 700
  • [28] Activity of cabazitaxel following docetaxel and abiraterone acetate in patients with castration-resistant prostate cancer
    Sella, Avishay
    Sella, Tal
    Peer, Avivit
    Berger, Raanan
    Frank, Stephen Jay
    Gez, Eli
    Sharid, David
    Hayat, Henry
    Hanovich, Ekaterina
    Kovel, Svetlana
    Rosenbaum, Eli
    Neiman, Victoria
    Keizman, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [29] Optimal Timing of Cabazitaxel Introduction for Japanese Patients With Metastatic Castration-resistant Prostate Cancer
    Ito, Toshiki
    Kanao, Kent
    Takahara, Kiyoshi
    Ando, Ryosuke
    Yasui, Takahiro
    Shiroki, Ryoichi
    Sumitomo, Makoto
    Miyake, Hideaki
    ANTICANCER RESEARCH, 2019, 39 (06) : 3089 - 3094
  • [30] Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer
    Thibault, Constance
    Eymard, Jean-Christophe
    Birtle, Alison
    Krainer, Michael
    Baciarello, Giulia
    Flechon, Aude
    Le Moulec, Sylvestre
    Spaeth, Dominique
    Laguerre, Brigitte
    Caffo, Orazio
    Deville, Jean-Laurent
    Beuzeboc, Phillipe
    Hasbini, Ali
    Gross-Goupil, Marine
    Helissey, Carole
    Bennamoun, Mostefa
    Hardy-Bessard, Anne-Claire
    Oudard, Stephane
    EUROPEAN JOURNAL OF CANCER, 2018, 97 : 41 - 48
12345